A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years
Open Access
- 18 July 2011
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 29 (32), 5195-5202
- https://doi.org/10.1016/j.vaccine.2011.05.031
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Inc
This publication has 15 references indexed in Scilit:
- Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adultsPediatrics International, 2008
- Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological MemoryClinical Infectious Diseases, 2008
- Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adultsVaccine, 2007
- Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodiesVaccine, 2007
- Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate VaccinePublished by American Medical Association (AMA) ,2005
- Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal PolysaccharidesClinical and Vaccine Immunology, 2003
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Analysis of Studies to Evaluate Immune Response to Combination VaccinesClinical Infectious Diseases, 2001
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Test‐Based Exact Confidence Intervals for the Difference of Two Binomial ProportionsBiometrics, 1999